CYRX (CryoPort, Inc. Common Stock) Stock Analysis - Community

CryoPort, Inc. Common Stock (CYRX) is a publicly traded Industrials sector company. As of May 21, 2026, CYRX trades at $14.09 with a market cap of $670.85M and a P/E ratio of 10.38. CYRX moved +7.83% today. Year to date, CYRX is +43.13%; over the trailing twelve months it is +108.75%. Its 52-week range spans $4.58 to $14.36. Analyst consensus is strong buy with an average price target of $13.58. Rallies surfaces CYRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade CYRX?

Rallies community data for CYRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

CYRX Key Metrics

Key financial metrics for CYRX
MetricValue
Price$14.09
Market Cap$670.85M
P/E Ratio10.38
EPS$1.34
Dividend Yield0.00%
52-Week High$14.36
52-Week Low$4.58
Volume696
Avg Volume0
Revenue (TTM)$182.94M
Net Income$76.05M
Gross Margin47.19%

Latest CYRX News

Recent CYRX Insider Trades

  • STEFANOVICH ROBERT sold 1.09K (~$8.95K) on Mar 23, 2026.
  • SHELTON JERRELL sold 2.89K (~$23.67K) on Mar 23, 2026.
  • Sawicki Mark W sold 1.34K (~$10.97K) on Mar 23, 2026.

CYRX Analyst Consensus

7 analysts cover CYRX: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.58.

Common questions about CYRX

How does the Rallies community trade CYRX?
Rallies community data for CYRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for CYRX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for CYRX when enough community data is available.
Is CYRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CYRX. It does not provide personalized investment advice.
CYRX

CYRX